Cerium Pharmaceuticals, Inc.
PrivateLast Round
Seed
May 22, 2026
Total Funding Raised
$19M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cerium Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a Series B round in November 2021.
Cerium Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines for rare and orphan diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerium Pharmaceuticals, Inc. Comparables
Compare Cerium Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kezar Life Sciences | 75% | |
| Dimerix Ltd | 73% | |
| Vertex Pharmaceuticals | 72% |
For institutional investors. Book with your work email.
Cerium Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 22, 2026 | ||||
| Series B | Nov 9, 2021 | ||||
| Early Funding | Jun 13, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2026
$750K raised in Seed Round.
- May 14, 2026
Monthly visitors increased 61% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 15, 2026
In Aug '26, Cerium Pharma receives $750K in venture funding in Maryland to develop medicines for patients with rare diseases, including pediatric and extremely rare conditions.
For institutional investors. Book with your work email.
Cerium Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cerium Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Cerium Pharmaceuticals, Inc. a public or private company?
Cerium Pharmaceuticals, Inc. is a private company.
What is the current stock price of Cerium Pharmaceuticals, Inc.?
Cerium Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Cerium Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cerium Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Cerium Pharmaceuticals, Inc. is not publicly available.
Can I buy Cerium Pharmaceuticals, Inc. stock?
Cerium Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cerium Pharmaceuticals, Inc.'s last funding round?
Cerium Pharmaceuticals, Inc.'s most recent funding round was Seed on May 22, 2026.
Who are the main investors in Cerium Pharmaceuticals, Inc.?
Investor information for Cerium Pharmaceuticals, Inc. is not publicly disclosed.
Will Cerium Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Cerium Pharmaceuticals, Inc..
How can I track Cerium Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cerium Pharmaceuticals, Inc.'s shares on secondary markets.